"type-2-diabetes-2"

Novo Nordisk has launched its once-weekly diabetes and weight-management drug Ozempic in India. The semaglutide-based GLP-1 agonist improves glycaemic control, supports weight loss and may reduce cardiovascular and kidney risks. Prices start at Rs 8,800 per month for the lowest dose

Children are developing obesity and metabolic syndrome early because of the dietary shift towards more processed and fast foods

The findings of a long-term study, published online in the Journal of Neurology Neurosurgery & Psychiatry, showed that men with cardiovascular disease risk factors can have dementia onset a decade earlier -- from their mid-50s to mid-70s -- than similarly affected women who are most susceptible from their mid-60s to mid-70s

Published in Cell Reports, the study could pave the way for innovative treatments for type 2 diabetes and other chronic diseases by promoting the differentiation of fat stem cells into smaller, healthier fat cells. Researchers from the University of California-Los Angeles (UCLA) were the first to reveal that obesity hampers the body's ability to produce essential cellular components known as ribosomal factors.

Previous studies have suggested that people with a late chronotype—those who prefer to go to bed and wake up late—tend to live less healthy lifestyles and are at greater risk for obesity and metabolic disorders, including type 2 diabetes. The new study found that individuals with a late chronotype face a 46% higher risk of developing diabetes, indicating that this increased risk cannot be attributed to lifestyle factors alone.

Prediabetes is characterized by elevated blood sugar levels and a heightened risk of developing Type 2 diabetes.

The National Institutes of Health financed study, published in Diabetes Care, highlight the importance of getting enough sleep in lowering one's chance of developing type 2 diabetes, which occurs when the body fails to effectively use a critical hormone, insulin, to maintain appropriate blood sugar levels.

The study was conducted at UIC and enrolled 75 participants into three groups: those who followed the time-restricted eating rules, those who reduced calories and a control group. Participants' weight, waist circumference, blood sugar levels and other health indicators were measured over the course of six months.

The latest cross-sectional study included 1,923 adults living in the community across 8 provinces in China

The findings were broadly similar in analyses using EU data, with corresponding estimates being about 13, 9, or 5 years earlier death on average.

Kombucha is a tea fermented with bacteria and yeasts and was consumed as early as 200 BC in China, but it did not become popular in the US until the 1990s

In a study published in the scientific journal eLife, it was revealed that inherent genetic variations can cause certain individuals to accumulate waist fat while simultaneously offering protection against diabetes.

The study also showed that 136 million Indians are pre-diabetic, 213 million people live with high cholesterol, 185 million suffer from high LDL cholesterol or bad cholesterol.

Researchers have known that a lack of quality sleep can increase a person's risk of diabetes.

Canagliflozin is a drug that controls blood sugar levels in people with type 2 diabetes, however researchers have found an unexpected role for the drug involving the human immune system

The WHO stated that these sweeteners had undesirable effects like increased risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.

Type 2 diabetes is the world’s most prevalent chronic disease and often described as the silent killer. There are many drugs available for the disease yet patients are not able to maintain healthy levels of blood glucose.

Strengths of the study are that it includes a large number of people from several European countries and validated, standard methods to diagnose cancer.

To compare the potential benefits of whey protein, the same participants also spent a week drinking a control shot that contained no protein in order to measure the results against each other.

The researchers of the study, to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD), said semaglutide reduces the future risk of diabetes by over 60 per cent in patients with obesity.